The roles of AMP-activated protein kinase (AMPK) and myocyte enhancer factor 2 isoforms (MEF2A, D) as mediators of the effects of ethanol on glucose transporter 4 (GLUT4) expression are unclear. We studied the effects of ethanol in adipocytes in vivo and in vitro. Methods: Thirty-six male Wistar rats were divided into three groups and given ethanol in a single daily dose of 0, 0.5, or 5 g/kg for 22 weeks. The expression of AMPK, MEF2 isoforms A and D, and GLUT4 was measured and compared in the three groups. The existence of the AMPK/MEF2/GLUT4 pathway in adipocytes and the effects of ethanol on this pathway were studied in (a) epididymal adipose tissue from six male Wistar rats subcutaneously injected with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR, an AMPK activator) or with 0.9% NaCl (control); and (b) isolated rat and human adipocytes treated with or without ethanol, AICAR, and compound C (a selective AMPK inhibitor). Expression of AMPK, MEF2, and GLUT4 was measured by RT-PCR and Western blotting. Results: (1) Long-term ethanol exposure decreased activated AMPK, MEF2A, MEF2D, and GLUT4 expression in rat adipose tissue. (2) In rat and human adipocytes, AICAR-induced AMPK activation, with subsequent elevation of MEF2 and GLUT4 expression, was inhibited by compound C. (3) In vitro ethanol-treatment suppressed the AMPK/MEF2/GLUT4 pathway. Conclusion: The AMPK/MEF2/GLUT4 pathway exists in both rat and human adipocytes, and activated AMPK may positively regulate MEF2 and GLUT4 expression. Ethanol inhibition of this pathway leads to decreased GLUT4 expression, thus reducing insulin sensitivity and glucose tolerance.
Introduction
Previous studies have demonstrated the important role of adipose tissue GLUT4 expression in determining insulin sensitivity. Adipocyte-specific GLUT4 -/-mice develop insulin resistance and glucose intolerance [1] , while mice with adiposespecific overexpression of GLUT4 have enhanced insulin sensitivity [2] . The effect of ethanol on adipose tissue GLUT4 expression is complex. When rats are given a normal diet, chronic ethanol exposure is reported to decrease GLUT4 expression [3, 4] and surface accessibility [5] . However, when rats are given a high-fat diet, chronic ethanol administration increases GLUT4 expression [6] . In addition, the mechanism of action of ethanol on GLUT4 is still obscure. In addition to the phosphoinositide 3-kinase (PI3K)-dependent pathway [7, 8] , others have proposed that G protein [4, 9] and Cb1/TC10 [10] pathways are involved in the effect of ethanol on GLUT4. Recently, AMP-activated protein kinase (AMPK) has been suggested to be a new target for ethanol, but the effect of ethanol on AMPK activation is now controversial. Several groups have reported that AMPK activity could be inhibited by ethanol in both hepatic cells [11, 12] and brain cells of mice at postnatal day 7 [13, 14] . However, HongBrown reported that incubation of C2C12 myocytes with 100 mmol/L ethanol markedly increases AMPK phosphorylation and activity [15] . Our previous study demonstrated that longterm ethanol exposure restores AMPK activity in the adipose Long-term ethanol exposure inhibits glucose transporter 4 expression via an AMPK-dependent pathway in adipocytes Li FENG 1, 2, # , Yong-feng SONG 1, # , Qing-bo GUAN 1 www.nature.com/aps Feng L et al Acta Pharmacologica Sinica npg tissue of high-fat diet-fed rats [6] . The AMPK heterotrimer consists of a catalytic α subunit and two regulatory β and γ subunits [16, 17] . There are multiple isoforms of each subunit: α1 and α2; β1 and β2; and γ1, 2, and 3 [18] . AMPK is activated by a mechanism that involves allosteric modification and phosphorylation of Thr172 in the α subunit [19] . Activated AMPK stimulates GLUT4 expression [20] and basal GLUT4 translocation in both skeletal muscle and adipocytes [21] [22] [23] [24] . Moreover, studies in cardiac and skeletal muscle have found that AMPK regulates GLUT4 in a manner dependent upon a heterodimer of MEF2A and MEF2D (myocyte enhancer factor 2) [25] [26] [27] , a complex that can bind to the human GLUT4 promoter [26] and thus regulate GLUT4 transcription.
In the present study, we investigated the effects of ethanol on the AMPK/MEF2/GLUT4 pathway in isolated rat and human primary adipocytes both in vitro and in vivo.
Materials and methods

Animal feeding
Thirty-six male Wistar rats (weight, 160−180 g; Laboratory Animal Center of Shandong University) were housed in individual cages in a temperature-controlled room (24 °C) on a 12-h light-dark cycle and fed pelleted commercial normal chow diet containing 10% fat, 70% carbohydrate, and 20% protein (total 4.5 kcal/g, Animal Center of Shandong University). After acclimatization for one week, the rats were divided into three groups and given edible ethanol (Ji-nan Baotu Spring Distillery, Shandong, China) at a single daily dose of 0.5 g/kg body weight (low dose, group L) or 5 g/kg (high dose, group H) or distilled water (controls, group C) at 8-9 am by gastric tube. The animal study was approved by the Shandong University Institutional Animal Care and Use Committee (Ji-nan, China).
Oral glucose tolerance test (OGTT)
OGTT was carried out after a 22-week ethanol treatment. Rats were fasted overnight; blood glucose was then measured in samples obtained by tail bleeding before administration of glucose (2 g·kg -1 body weight) and at 30, 60, and 120 min after glucose. Blood glucose concentrations were determined using a One Touch SureStep Meter (Life Scan, Milpitas, CA). The area under the curve (AUC) was calculated to assess glucose tolerance.
Determination of plasma ethanol concentration
On the day of the study, two hours after ethanol administration, blood samples were obtained from the jugular sinus and were rapidly stored in tubes with seals. Plasma ethanol concentrations were determined using a dry chemical method (Johnson & Johnson, USA).
Tissue collection
All rats were allowed to recover from OGTT for three days before sacrifice. Rats were anesthetized by an intraperitoneal injection of sodium pentobarbital (0.1 mL/100 g BW) after a 10-h fast. Blood samples were obtained from the inferior vena cava for glucose and insulin determination. Epididymal and perirenal fat pads were rapidly removed and weighed. Ratios of epididymal and perirenal adipose tissue weight (g) to body weight (g) were calculated. Portions of the epididymal fat samples were fixed in 4% (w/v) paraformaldehyde-0.2 mol/L phosphate-buffered saline (PBS, pH 7.4) for immunofluorescence and hematoxylin & eosin (H&E) staining analysis. The remaining tissues were frozen in liquid nitrogen for messenger RNA and protein analyses.
Biochemical analysis and evaluation of insulin sensitivity Blood glucose was measured using the glucose oxidase method. Insulin was measured by radioimmunoassay (Northern Bioengineering Institute, China). HOMA-IR was calculated using the following formula: FPG (mmol/L)×FINS (mU/ mL)/22.5 [28] .
AICAR injection
Six male Wistar rats weighing 170−180 g were randomly divided into two groups and injected subcutaneously with AICAR (an AMPK activator, 0.8 mg/g body weight, AICAR group) or a corresponding volume of 0.9% NaCl (control group). Two hours later, epididymal adipose tissues were obtained as described above for mRNA and protein analysis.
Isolation of rat and human adipocytes
Adipocytes were isolated from the epididymal fat pad of normal male Wistar rats (weighing 250-300 g) and from the omental adipose tissue of male patients aged 25−55 undergoing abdominal surgery at the Shandong Provincial Hospital (Jinan, China) in 2007. Patients with a history of ethanol ingestion or diabetes were excluded. All patients gave written informed consent for tissue donation before surgery. The human study was approved by the Ethics Committee of Shandong Provincial Hospital (Ji-nan, China). All visible blood vessels were carefully removed from the fat tissue [29, 30] . The fat pads were minced into millimeter-sized pieces, digested in Krebs-Ringer bicarbonate HEPES (KRBH) buffer (120 mmol/L NaCl, 4 mmol/L KH 2 PO 4 , 1 mmol/L MgSO 4 , 0.75 mmol/L CaCl 2 , 10 mmol/L NaHCO 3 , 30 mmol/L HEPES; pH 7.4) with 1 mg/mL collagenase type I, 1% (w/v) BSA, 2.5 mmol/L glucose, 100 μg/mL penicillin, 100 μg/mL streptomycin, and 1% (v/v) fungizone for 40-60 min in a 37 °C water bath with gentle agitation. After being filtered sequentially through 500-and 250-μm nylon mesh, the adipocyte cell suspension was centrifuged at 800×g at room temperature for 2 min. After several washes, cells were resuspended in KRBH buffer (pH 7.4) with 1% BSA and 2.5 mmol/L glucose, allowed to equilibrate for 30 min at 37 °C, and then used directly for the subsequent experiments. Cell concentration was adjusted to 1.0×10 6 cells/mL.
Cell culture and treatment
The isolated adipocytes were placed at a concentration of 1×10 7 /100 mm per culture dish and incubated for 1 h in [31] [32] [33] . Rat and human adipose cells were incubated at 37 °C for 1 h in the absence or presence of ethanol (100 mmol/L), AICAR (1 mmol/L), and compound C (a selective inhibitor of AMPK, 20 μmol/L). Compound C treatment was initiated 20 min before adding AICAR.
RNA extraction and RT-PCR
Total RNA was extracted from frozen epididymal adipose tissue and adipocytes using the standard Trizol RNA isolation method. The quality of RNA was checked using the DU640 nucleic acid analyzer (Beckman, USA). Reverse transcription of 4 μg of RNA was carried out according to the instructions of the Fermentas RevertAid TM First Strand cDNA Synthesis Kit (#K1622).
All primers were synthesized by the Shanghai Sangon Biotechnology Corporation (Shanghai, China) and the sequences are shown in Table 1 . PCR amplification was carried out in a total reaction volume of 25 μL, including 2.5 μL PCR buffer (10×), 0.2 μL Taq polymerase, 2 μL dNTP (TaKaRa, 2.5 mmol/L), 2 μL MgCl 2 (TaKaRa, 25 mmol/L), 2 μL primers (5×10 -6 mol/L) and 2.5−3 μL of the cDNA (2.5 μL for AMPK α1, α2, and GLUT4; 3 μL for MEF2A). The PCR products were subjected to 1.5% agarose gel electrophoresis containing ethidium bromide and visualized by excitation under UV light, quantified using Alphaimager 2200. GAPDH was used as an internal control for quantity and quality.
Total, nuclear, and cytoplasmic protein extraction Epididymal adipose tissue samples were crushed into powder in liquid nitrogen. Either the tissue powder or the isolated adipocytes were lysed in RIPA buffer containing 1×PBS, 1% NP-40, 0.1% SDS, 5 mmol/L EDTA, 0.5% sodium deoxycholate, 1 mmol/L sodium orthovanadate, and 1% phenylmethylsulfonyl fluoride. The lysate was sonicated twice for 10 s each on ice and centrifuged at 12 000×g for 8 min at 4 °C. Below the lipid layer, the soluble supernatant was carefully removed, avoiding the unhomogenized material at the bottom of the centrifuge tube, to obtain total protein. Nuclear and cytoplasmic proteins were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce). Protein content was measured using the Lowry Protein Assay Kit (Bio-Rad, USA).
Western blotting
Protein samples (60 μg) were resolved by SDS-PAGE (10% resolving gels for total AMPKα, phosphorylated AMPKα, total-MEF2, MEF2A, MEF2D, and GLUT4; 6% resolving gels for phosphorylated acetyl-CoA carboxylase, pACC) and transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). All membranes were incubated overnight at 4 °C with primary antibodies against total AMPKα (rabbit polyclonal antibody, 1:1000 dilution, Cell Signaling, Danvers, MA,USA), pAMPKα (rabbit polyclonal antibody, 1:1000 dilution, directed against both α1 and α2 isoforms of the enzyme phosphorylated at Thr172, Cell Signaling, Danvers, MA,USA), pACC (rabbit polyclonal antibody, Ser-79; 1:1000 dilution, Cell Signaling, Danvers, MA, USA), MEF2 (rabbit polyclonal antibody, 1:100 dilution, Santa Cruz, USA), MEF2A (rabbit monoclonal antibody, 1:1000 dilution, Abcam Ltd, Cambridgeshire, UK ), MEF2D (goat polyclonal antibody, , and immunoreactive bands were quantified using Alphaimager 2200. Expression of β-actin was measured as an internal loading control by reblotting the membranes with mouse antirat β-actin monoclonal antibody (1:10 000 dilution, Abcam Ltd, Cambridgeshire, UK). The relative target protein levels were normalized to β-actin.
Immunofluorescence and hematoxylin and eosin (H&E) staining
The fixed epididymal adipose tissue was embedded in paraffin, and 5-µm sections were obtained. The glass-mounted sections were cleared from paraffin with xylene and rehydrated by sequential washings with graded ethanol solutions (70%-100%), subsequently incubated in 3% H 2 O 2 in methanol for 10 min to quench the endogenous peroxidase activity, pretreated in a microwave oven in sodium citrate buffer (pH 7.4) for 20 min with the temperature always kept at 95-98 °C, and then cooled at room temperature for 20 min to ensure recovery of protein spatial configuration. After being washed with PBS, the sections were blocked by 10% secondary antibody homologous sera (goat serum) in PBS for 2 h at room temperature, followed by overnight incubation with the primary antibody (rabbit anti-GLUT4, 1:300 dilution) in 5% goat serum in PBS at 4 °C in a moisture chamber. Negative controls for immunospecificity were included in all experiments, and the primary antibody was replaced by PBS or matching concentrations of normal rabbit or mouse serum [34] . All sections were then incubated with a FITC-conjugated anti-rabbit secondary antibody (1:150 dilution) for 1 h at room temperature. After sections were mounted with DAPI in PBS, analysis and photodocumentation were performed using a fluorescent microscope (Leica Microsystems GmbH, Wetzlar, Germany). The obtained sections were also stained with H&E and then examined under an optical microscope.
Statistical analyses
All of the experiments were repeated at least four times. All values are presented as means±SD. Data were analyzed using SPSS 11.5 software (SPSS, Inc, Chicago, IL). Statistical significance was assessed by one-way ANOVA. P<0.05 was considered statistically significant.
Results
Characteristics of rats after 22-week treatment As shown in Table 2 , all three groups were of similar body weights at baseline. After 22 weeks of treatment, ethanol-fed rats showed lower body weights, and high-dose ethanol feeding led to a greater reduction in body weight than low-dose ethanol (393.8±56. 5 Long-term ethanol consumption induces glucose intolerance in rats Long-term ethanol consumption, both in low and high dosages, increased glucose levels at the time points before and after the glucose load, but the increases were not significant. Deterioration in glucose tolerance (11% enhancement in glucose AUC, P<0.05 vs controls) was observed in high-dose etha- (Figure 1 ).
Long-term ethanol feeding reduces GLUT4 expression in rat adipose tissue
In epididymal adipose tissue of ethanol-fed rats, GLUT4 mRNA levels decreased by 28% (group L, P<0.05) and 47% (group H, P<0.01), respectively (Figure 2A) , and the corresponding protein levels decreased by 21% (group L, P<0.05) and 40% (group H, P<0.01), respectively, relative to the controls ( Figure 2B ). High-dose ethanol had a greater inhibitory effect on GLUT4 mRNA and protein expression than lowdose ethanol (both P<0.05 vs group L). To confirm the action of ethanol on GLUT4 expression, adipose tissue sections were stained by immunofluorescence. The specific immunofluorescence signal was absent in the negative control sample. Compared to non-ethanol-fed rats, weaker signals for GLUT4 expression were observed in the ethanol-fed rat adipose tissue, and the effect of ethanol was dose dependent ( Figure  2C ). These data show that ethanol feeding decreased GLUT4 expression in rat adipose tissue.
Ethanol suppresses MEF2 expression
With the description of a functional MEF2A/MEF2D heterodimer binding site in the rat and human GLUT4 promoters [35, 36] , MEF2 is considered a transcriptional regulator of GLUT4. To explore whether MEF2 was involved in the inhibitory effect of ethanol on GLUT4 expression, we measured the expression of total MEF2 and its two isoforms, MEF2A and D, in adipose tissue exposed to ethanol. Figure 3A shows that while the MEF2A mRNA level was not affected by ethanol, the MEF2D isoform was reduced by 9% in group L (P>0.05) and 23% in group H (P<0.01) relative to the controls ( Figure  3A) . The total MEF2 protein levels were correspondingly decreased by 24% (P<0.05) and 33% (P<0.05) in groups L and H, respectively, versus the controls ( Figure 3B) . The difference in MEF2D mRNA between groups H and L was statistically significant (P<0.05, Figure 3A and 3B). Similarly, total MEF2 protein levels were affected by the different dose of ethanol (P<0.05, Figure 3B ). We hypothesized that the ability of ethanol to decrease MEF2D mRNA expression might contribute, at least partially, to a decline in MEF2D protein. To test this, we measured the nuclear and cytoplasmic expression of MEF2D Figure  3C ). Moreover, for an analysis of MEF2A isoform, although the total MEF2A protein expression in group L and H was of no statistical significance relative to the control, the nuclear MEF2A level in group H was markedly lower than that in group L and C ( Figure 3C ).
Long-term ethanol feeding impairs AMPK activation but not expression
Recently, AMPK has been suggested as a new target for ethanol. Studies in skeletal muscle have shown that AMPK regulates GLUT4 via MEF2. To explore whether the decreased MEF2 and GLUT4 expression after ethanol treatment in adipose tissue was associated with the inhibition of AMPK, we measured the expression of AMPKα1 and α2 mRNA and total AMPKα and pAMPKα protein in rat adipose tissue. Our results show that mRNA expression of the AMPKα1 and α2 isoforms in ethanol-fed rats was not statistically different from that in control rats ( Figure 4A ). Consistent with this result, total AMPKα protein was also not affected by long-term ethanol feeding ( Figure 4B ). However, in ethanol-fed groups, the bands of phosphorylated AMPK protein detected by Western blotting were fainter than those in the control group (21% decrease in group L, P<0.05; 41% decrease in group H, P<0.01). Moreover, a much fainter phosphorylated AMPKα band was found in group H compared to group L (P<0.05, Figure 4B ), indicating that ethanol feeding impairs AMPK activation and that the impairment effect correlates with the ethanol dosage. and Western blotting, we determined MEF2 expression both at mRNA (A) and total protein (B) levels. We also measured nuclear, cytoplasmic, and total proteins of MEF2A and D, two isoforms of MEF2 (C) in adipose tissue. MEF2A, D mRNA levels were normalized by GAPDH and MEF2 protein levels were normalized by β-actin. Values are given as means±SD (n=12 for the low-dose ethanol and control group, n=10 for the high-dose ethanol group Activated AMPK positively regulates MEF2 and GLUT4 expression in rat adipose tissue Activated AMPK has been reported to regulate GLUT4 expression via MEF2 in skeletal muscle. In the present study, we found consistent changes in pAMPKα, MEF2, and GLUT4 in adipose tissue after long-term ethanol exposure, which prompted us to hypothesize that in adipose tissue, inhibition of AMPK activation might also result in decreased MEF2, which subsequently decreases GLUT4 expression. To test our hypothesis, rats were injected with AICAR. AICAR injection led to a marked increase in AMPKα phosphorylation in rat adipose tissues. As an indicator of AMPK activation, pACC was enhanced accordingly, indicating that the phosphorylation of AMPKα was followed by increased activity. Following the activation of AMPK, MEF2 protein level was elevated. As a result, GLUT4 mRNA levels were increased and, subsequently, its protein level increased. Our data show that activation of AMPK up-regulated MEF2 expression, with subsequent increases in GLUT4 expression in adipose tissue in vivo ( Figure 5 ).
Activated AMPK positively regulates MEF2 and GLUT4 expression in rat and human primary adipocytes To further confirm the up-regulation of MEF2 and GLUT4 expression by activated AMPK, rat and human primary adipocytes were treated with or without AICAR or compound C in vitro. As seen in Figure 6 , in AICAR-treated rat and human adipocytes, pAMPKα levels increased by 83% (P<0.01) and 91% (P<0.01), respectively, and pACC increased by 82% (P<0.01) and 53% (P<0.01), respectively. Subsequently, MEF2 levels also increased by 73% (P<0.01) and 54% (P<0.05), respectively. Corresponding GLUT4 mRNA levels were elevated by 52% (P<0.05) and 55% (P<0.05), respectively, and GLUT4 protein expression increased by 49% (P<0.05) and 40% (P<0.05), respectively. These results further confirmed our in vivo observations. However, if cells were preincubated with compound C prior to AICAR for 20 min, the effects of AICAR on activated AMPK, MEF2, and GLUT4 were inhibited to nearly normal levels. These data are consistent with our hypothesis that AMPK is an upstream positive regulator of MEF2 and GLUT4 in rat and human adipocytes.
Inhibition of AMPK activity by ethanol leads to decreased MEF2 and GLUT4 expression in rat and human adipocytes To investigate the action of ethanol on the AMPK/MEF2/ GLUT4 pathway, isolated rat and human adipocytes were treated with ethanol. Compared to the controls, ethanol decreased pAMPKα protein by 39% (P<0.05) and 56% (P<0.05) in rat and human adipocytes, respectively; decreased pACC expression by 49% (P<0.05) and 56% (P<0.01), respectively; and decreased MEF2 levels by 32% (P<0.05) and 45% (P<0.05), respectively. As a result, the mRNA and protein levels of GLUT4 were diminished by 52% (P<0.05) and 40% (P<0.05) in rat adipocytes and by 40% (P<0.01) and 60% (P<0.05) in human adipocytes (Figure 7 ), respectively. Taken together, these results suggest that the impairment of GLUT4 expression by ethanol is most likely due to the decline of AMPK activity and subsequent inhibition of MEF2 expression.
Discussion
Epidemiological studies suggest that chronic light or heavy ethanol consumption leads to insulin resistance, whereas moderate ethanol consumption results in increased insulin sensitivity [37] [38] [39] [40] [41] . In the present study, we found that long-term high-dose ethanol consumption led to insulin resistance in rats, which was consistent with previous studies. However, in low-dose ethanol-fed rats, insulin sensitivity as measured by the HOMA index was not statistically different from that of the controls. Consistent with our HOMA insulin sensitivity results, oral glucose tolerance was significantly impaired after high-dose ethanol feeding but did not change after low-dose ethanol consumption. The discrepancy between epidemiological studies and our findings is uncertain but may be due to the following reasons: (1) the HOMA index and OGTT, which were used in our study, are not as sensitive as the hyperinsulinemic euglycemic clamps and intravenous glucose tolerance test (IVGTT) used in the former studies; and (2) the development of insulin resistance and glucose intolerance induced by low-dose ethanol may take longer than 22 weeks and may be related to a threshold total accumulated dose of ethanol.
The mechanisms for the increase in insulin resistance or glucose intolerance induced by ethanol have not been well established. GLUT4 is a key molecule for glucose utilization in adipose tissue and skeletal muscle. The factors that can inhibit GLUT4 expression and/or translocation may lead to a disturbance of glucose utilization. Consistent with previous research [3] [4] [5] , we found that long-term ethanol consumption decreased GLUT4 expression at both the mRNA and the protein levels in rat adipose tissue. The inhibitory action of ethanol on GLUT4 expression in adipose tissue might be a key step in ethanol-induced insulin resistance, because changes in GLUT4 expression in adipose tissue are considered a key factor in determining whole body insulin sensitivity and may be more important than the changes in both skeletal muscle and Figure 5 . AICAR injection enhanced activation of AMPK, expression of MEF2 and GLUT4 in rat adipose tissue. Six male Wistar rats were subcutaneously injected with AICAR (n=3) or with a corresponding volume of 0.9% NaCl (controls, n=3). Two hours later, epididymal adipose tissues were obtained for analysis. GLUT4 mRNA expression was measured using RT-PCR. Protein expression of pAMPK α, pACC, MEF2, and GLUT4 was determined by Western blotting.
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Acta Pharmacologica Sinica npg liver [1] . Inhibition of GLUT4 mRNA expression prompted us to investigate the mechanism by which ethanol regulates GLUT4 transcription. MEF2 is a transcription factor that plays a key role in skeletal muscle differentiation [42] . It contains a known nuclear localization sequence that encompasses amino acids 472-507 in the primary sequence [43] , indicating that MEF2 can be translocated to the nucleus. Further studies indicate that MEF2 colocalizes to the nucleus with histone deacetylase 4 [44] . Since the identification of a functional MEF2 binding site located between -522 and -420 in the rat and human GLUT4 promoters [35, 36] , it is believed that MEF2 is a transcriptional regulator of GLUT4, because the truncation or deletion of this binding sequence in the GLUT4 promoter decreases GLUT4 mRNA expression [36] . In the present study, we found that chronic ethanol consumption decreased MEF2A and MEF2D expression at both the mRNA and the protein levels in rat adipose tissue. The inhibition of MEF2 expression by ethanol may help us to understand the decrease in GLUT4 mRNA expression. The reduced nuclear MEF2A and MEF2D levels could have resulted in the decreased formation of the MEF2A/MEF2D heterodimer. Subsequently, the heterodimers that bind to the GLUT4 promoter would also be decreased, which in turn would result in impaired GLUT4 expression. Based on our present results, we could not determine which isoform of MEF2 was most important for GLUT4 gene expression. However, based on other reports, it seems that MEF2D is more important than MEF2A in regulating GLUT4 expression in adipose tissue. Knight et al demonstrated that MEF2A, but not MEF2D, is an activator of the GLUT4 promoter [45] in the pancreas, kidney, skeletal muscle, liver, lung, placenta, brain, and heart. However, Mora et al [46] found that, in contrast to both cardiac and skeletal muscle, adipose tissue displays a selective decrease in MEF2D expression in diabetes without any significant alteration in MEF2A protein content. Furthermore, in vivo, the selective overexpression of MEF2A in adipose tissue does not affect GLUT4 expression and is not sufficient to pre- 
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Acta Pharmacologica Sinica npg vent the GLUT4 downregulation that occurs in insulin-deficient states [46] . The reason for the discrepancy between their results is still unclear, but the different tissues utilized might be a possible explanation. The relationships between the two isoforms of MEF2 and GLUT4 need further exploration.
AMPK has been demonstrated to be an upstream regulator for MEF2 and can increase MEF2 expression in skeletal muscle, resulting in up-regulation of GLUT4 transcription [47, 48] . The existence of this mechanism in adipose tissue after ethanoltreatment has not been studied. We investigated the expression of AMPKα1 and α2 mRNA, total AMPKα, and pAMPKα protein in ethanol-treated rat adipose tissue. Our results show that feeding rats ethanol resulted in a reduction in pAMPKα level without any significant effect on AMPKα1/2 mRNA or total AMPKα protein level, suggesting that ethanol affects the activation, but not expression of AMPKα. Activated AMPK can be translocated to the nucleus from the cytosol [48] , which could be the reason that MEF2 is affected at a transcriptional level in the nucleus. As an indicator of pAMPK activation, the decline in pACC further confirmed the decreased activation of AMPK after long-term ethanol feeding.
Although low-dose ethanol showed no significant influence on insulin sensitivity or glucose tolerance, the expression of AMPK, MEF2, and GLUT4 in rat adipose tissue was significantly reduced. Based on these findings, it is possible to conclude that changes at the molecular level may take place before any pathological consequences and that, with time, the negative effect of ethanol on insulin sensitivity will gradually become more significant.
In skeletal muscle, activated AMPK has been demonstrated to increase GLUT4 protein level and translocation [21, 49, 50] via MEF2 [25, 27, 48] . However, the findings in adipose tissue are controversial. Under basal conditions (no insulin stimulation), several studies have reported that the activation of AMPK by AICAR accelerates GLUT4 translocation and increases glucose uptake [23, 24] , whereas others have shown that glucose uptake is suppressed by activated AMPK in adipocytes, probably due to decreased translocation of GLUT4 [51] . To test whether an AMPK/MEF2/GLUT4 pathway existed in adipose tissues and to observe the regulation of MEF2 Figure 7 . Ethanol-treatment impaired AMPK/MEF2/GLUT4 pathway in rat and human adipocytes. Rat and human primary adipocytes were isolated as previously described (Materials and Methods). The cells were incubated at 37 °C for 1 h in the absence or presence of ethanol (100 mmol/L) and AICAR (1 mmol/L). GLUT4 mRNA expression was measured using RT-PCR. Protein expression of pAMPK α, pACC, MEF2, and GLUT4 was determined by Western blotting. show that AICAR increased pAMPKα levels in both adipose tissue and adipocytes. Parallel to the changes in pAMPKα, the level of pACC was also enhanced. Because ACC is a cytosolic protein and an indicator of AMPK activation, the increased pACC level reflects enhanced AMPK activation in the cytosol.
As a downstream molecule of AMPK in the nucleus, MEF2 expression was elevated after AICAR treatment. Therefore, from these results, we conclude that enhanced activation of AMPK increased MEF2 expression. MEF2 is reported to be a transcriptional regulator of GLUT4 in skeletal muscle. Therefore, we wanted to know whether increased MEF2 expression would lead to a rise in GLUT4 mRNA expression in adipocytes. As expected, both GLUT4 mRNA and protein levels were enhanced in AICAR-treated rat and human adipocytes. In adipocytes treated with the AMPK inhibitor compound C prior to AICAR for 20 min, the augmentation effects of AICAR on activated AMPK, MEF2, and GLUT4 levels were inhibited to a level close to normal. These findings indicate that GLUT4 expression in adipocytes is positively regulated by activated AMPKα via MEF2.
To further confirm the action of ethanol on the AMPK/ MEF2/GLUT4 pathway observed in vivo, primary adipocytes isolated from rat and human adipose tissue were incubated with ethanol. AMPK activation and MEF2 expression were inhibited by ethanol. Accordingly, mRNA and protein expression of GLUT4 were suppressed. The changes in this pathway in vitro further confirmed the findings we observed in vivo. However, the in vitro incubation time was only 1 h, which was not long enough to mimic the chronic effects of ethanol. We incubated cells for only 1 h for the following reasons. In our preliminary experiments, the longest survival time of isolated mature adipocytes was no more than 24 h. Moreover, in the preliminary experiments, we incubated the rat adipocytes with 100 mmol/L ethanol for different times (data not shown). The maximum inhibitory effect on AMPK phosphorylation was observed when adipocytes were treated with 100 mmol/L ethanol for 1 h. The inhibitory effect of ethanol was not enhanced when the incubation was prolonged to 120 min. Furthermore, ethanol is a volatile substance. With decreases of ethanol concentration in the medium, the inhibitory effect of ethanol was weakened. Therefore, to maintain cell activity and mimic the effects of high-dose ethanol in vitro, one hour was chosen for the in vitro experiments.
In an earlier study, we reported that the addition of ethanol to a high fat diet ameliorated the effects of the high fat diet and increased GLUT4 expression. In the present study, we found that ethanol decreased GLUT4 expression. The findings clearly indicate that the effect of ethanol on GLUT4 expression is more complex than previously thought. A comparison of the two experiments suggests some possible reasons for the discrepancy. First, although the animals in both studies received the same total daily ethanol dosage, the frequencies of ethanol intake were different. Previously, rats received ethanol twice daily, while here they received it only once daily. The different frequencies of ethanol intake led to different plasma ethanol concentrations (87±24.9 mg/dL in the present study, 10.8±3.6 mg/dL in the earlier experiment), resulting in different outcomes even though the average daily ethanol consumption was similar [52, 53] . Administration of ethanol once daily at 0.5 and 5 g/kg might mimic the effects of light and heavy ethanol consumption, respectively, whereas twice daily administration at the dosage of 5 g/kg might mimic the effects of moderate ethanol consumption. Second, it is possible that a counteractive effect may exist between ethanol and a high-fat diet. For example, ethanol attenuates fatty acid-induced apoptosis in neonatal rat cardiomyocytes [54] . Diets rich in saturated fatty acids protect against alcoholic liver injury [55] [56] [57] [58] [59] [60] . Furthermore, administration of saturated fat has been shown to reverse established alcoholic liver injury in rats and improve nearly all liver pathological changes, despite continued ethanol administration [61, 62] . Based on these data, our present findings suggest that the adverse effects of a high-fat diet might be countered by the addition of ethanol, with a restoration of GLUT4 expression, but that such an effect would not be observed when rats were fed a normal diet.
In conclusion, we demonstrate that an AMPK/MEF2/ GLUT4 pathway exists in adipose tissue and that activated AMPK up-regulates GLUT4 expression via MEF2. Inhibition of this pathway by long-term ethanol feeding, at least in part, contributes to the impairment of GLUT4 expression in adipose tissue, thus decreasing insulin sensitivity and glucose tolerance. 
